권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Title Page
Contents
Abstract 5
1. Introduction 7
2. Materials and methods 10
Cell culture 10
Flow Cytometry 10
Western blot analysis 11
Immunofluorescence 12
3. Result 14
Selection of breast cancer cell lines for experiment 14
Neuregulin-1 induces increase of CD44-positive CSC fraction. 15
Neuregulin-1 induces expression of CSC markers. 17
4. Discussion 19
5. Reference 23
Figure 29
In breast cancer, neuregulin-1 is known as a ligand for the HER3 receptor, which has no intrinsic tyrosine kinase activity. Activated Her3 receptor by neuregulin-1 binding forms heterodimer with other Her receptor family and mediates downstream signaling pathways, leading to multiple effects, including growth, proliferation, decreased apoptosis, cellular migration, and angiogenesis.
Cancer stem cell (CSC), a subgroup of cancer cell, is considered to have features of stem cells such as self-renewal ability and pluripotent differentiation into other types of mature cell. CSCs and their relation to the tumor recurrence, metastasis, and chemo-resistance draw attention in these days.
This study showed that neuregulin-1 treatment induces CSC characteristics in breast cancer cell lines. Using breast cancer cell lines such as MCF7, SKBr3, MDA-MB 468, changes related to the CSC characteristics were analyzed. In MCF7 and SKBr3 cells, increase of CSC fraction and expression of CSC markers were observed after neuregulin-1 treatment. However, MDA-MB 468 cells showed intrinsic high expression of CSC markers and high cellular fraction of CSCs. In MDA-MB 468 cells, neuregulin-1 treatment made no significant change in CSC characteristics. The result implies a presence of mechanism by which the activated Her receptors by neuregulin-1 contribute to acquire the CSC-like characteristics in some types of breast cancer.*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.